Silverarc Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.66M	Sell	178,378 -12,696	-7%	-$346K	0.67%	42
2025 Q4	$5.19M	Sell	191,074 -157,848	-45%	-$4.16M	0.75%	38
2025 Q3	$9.03M	Buy	348,922 +150,481	+76%	+$3.49M	1.31%	29
2025 Q2	$4.04M	Sell	198,441 -7,521	-4%	-$146K	0.83%	31
2025 Q1	$3.74M	Sell	205,962 -58,598	-22%	-$1.31M	0.78%	34
2024 Q4	$6.69M	Buy	264,560 +119,560	+82%	+$3.25M	1.49%	24
2024 Q3	$4.93M	Sell	145,000 -229,910	-61%	-$8.76M	1.11%	34
2024 Q2	$13.9M	Buy	374,910 +75,594	+25%	+$2.85M	3.43%	9
2024 Q1	$12.6M	Buy	299,316 +52,101	+21%	+$2.14M	3.52%	6
2023 Q4	$9.8M	Buy	+247,215	New	+$7.27M	3.02%	11
2023 Q3	–	Sell	-10,000	Closed	-$339K	–	85
2023 Q2	$339K	Sell	10,000 -74,651	-88%	-$2.52M	0.11%	72
2023 Q1	$3.05M	Buy	84,651 +29,952	+55%	+$1.29M	1.37%	31
2022 Q4	$2.44M	Buy	54,699 +1,424	+3%	+$50.8K	0.84%	49
2022 Q3	$1.5M	Buy	53,275 +16,953	+47%	+$520K	0.64%	52
2022 Q2	$979K	Sell	36,322 -9,216	-20%	-$268K	0.46%	55
2022 Q1	$256	Buy	45,538 +406	+0.9%	+$13K	0.12%	61
2021 Q4	$1.74M	Buy	45,132 +6,889	+18%	+$300K	0.78%	41
2021 Q3	$2.06M	Buy	38,243 +28,322	+285%	+$1.33M	1.2%	27
2021 Q2	$2.93K	Buy	+9,921	New	+$272K	1.43%	25
2021 Q1	–	Sell	-80,282	Closed	-$1.41M	–	95
2020 Q4	$1.41M	Buy	+80,282	New	+$1.44M	0.86%	43